OPKO Health - 29 Year Stock Price History | OPK
- The all-time high OPKO Health stock closing price was 19.12 on June 03, 2015.
- The OPKO Health 52-week high stock price is 1.75, which is 15.9% above the current share price.
- The OPKO Health 52-week low stock price is 0.85, which is 43.7% below the current share price.
- The average OPKO Health stock price for the last 52 weeks is 1.32.
OPKO Health Historical Annual Stock Price Data | ||||||
---|---|---|---|---|---|---|
Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
2024 | 1.2888 | 1.5700 | 1.6800 | 0.8655 | 1.5100 | 0.00% |
2023 | 1.5303 | 1.2200 | 2.1700 | 1.0600 | 1.5100 | 20.80% |
2022 | 2.5910 | 4.9300 | 4.9300 | 1.0500 | 1.2500 | -74.01% |
2021 | 4.1099 | 4.2000 | 5.9900 | 3.3300 | 4.8100 | 21.77% |
2020 | 3.0656 | 1.4900 | 5.9550 | 1.1500 | 3.9500 | 168.71% |
2019 | 2.2225 | 3.2900 | 3.8300 | 1.4200 | 1.4700 | -51.16% |
2018 | 4.1177 | 4.9700 | 6.2900 | 2.4600 | 3.0100 | -38.57% |
2017 | 6.8778 | 9.0900 | 9.3800 | 4.6100 | 4.9000 | -47.31% |
2016 | 9.9056 | 10.0000 | 11.9100 | 7.6600 | 9.3000 | -7.46% |
2015 | 12.9449 | 9.9300 | 19.1200 | 8.4100 | 10.0500 | 0.60% |
2014 | 8.7105 | 8.4100 | 9.9900 | 7.5800 | 9.9900 | 18.36% |
2013 | 7.9517 | 5.0000 | 12.3500 | 5.0000 | 8.4400 | 75.47% |
2012 | 4.6262 | 4.8800 | 5.4800 | 4.0900 | 4.8100 | -1.84% |
2011 | 4.2107 | 3.9300 | 5.6600 | 3.2800 | 4.9000 | 33.51% |
2010 | 2.3495 | 1.9500 | 3.8800 | 1.6300 | 3.6700 | 100.55% |
2009 | 1.6651 | 1.5800 | 2.7600 | 0.6000 | 1.8300 | 12.96% |
2008 | 1.9220 | 2.8900 | 3.4000 | 1.0800 | 1.6200 | -43.16% |
2007 | 3.5006 | 0.9000 | 5.3500 | 0.9000 | 2.8500 | 235.29% |
2006 | 0.5766 | 0.4100 | 1.0400 | 0.3800 | 0.8500 | 107.32% |
2005 | 0.3967 | 0.3200 | 0.4700 | 0.3200 | 0.4100 | 20.59% |
2004 | 0.6651 | 0.8500 | 1.1400 | 0.3350 | 0.3400 | -62.18% |
2003 | 0.5503 | 0.4900 | 0.9900 | 0.3300 | 0.8990 | 156.86% |
2002 | 1.0891 | 3.2000 | 3.2000 | 0.3500 | 0.3500 | -89.49% |
2001 | 4.0984 | 7.1250 | 8.0000 | 2.2000 | 3.3300 | -54.85% |
2000 | 9.3672 | 7.8100 | 17.5000 | 5.0000 | 7.3750 | -1.67% |
1999 | 7.0873 | 7.3750 | 9.0000 | 5.4380 | 7.5000 | 9.09% |
1998 | 7.7877 | 7.0630 | 14.5000 | 3.2500 | 6.8750 | 0.00% |
1997 | 4.7071 | 2.3750 | 11.0600 | 2.3750 | 6.8750 | 224.29% |
1996 | 3.8806 | 4.2500 | 6.0000 | 2.0000 | 2.1200 | -50.12% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Instruments Manufacturing | $1.053B | $0.864B |
OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Thermo Fisher Scientific (TMO) | United States | $213.123B | 26.03 |
Intuitive Surgical (ISRG) | United States | $180.348B | 94.29 |
Alcon (ALC) | Switzerland | $45.275B | 31.87 |
Edwards Lifesciences (EW) | United States | $40.686B | 25.30 |
IQVIA Holdings (IQV) | United States | $37.963B | 20.92 |
IDEXX Laboratories (IDXX) | United States | $34.345B | 40.24 |
DexCom (DXCM) | United States | $27.478B | 41.38 |
Waters (WAT) | United States | $22.986B | 34.00 |
STERIS (STE) | Ireland | $22.207B | 25.91 |
SONOVA HOLDING (SONVY) | Switzerland | $21.889B | 0.00 |
Hologic (HOLX) | United States | $19.123B | 20.79 |
Fresenius Medical Care AG KGaA (FMS) | Germany | $11.596B | 13.00 |
Sysmex ADR (SSMXY) | Japan | $11.505B | 0.00 |
Globus Medical (GMED) | United States | $10.139B | 28.36 |
Teleflex (TFX) | United States | $9.809B | 15.65 |
Penumbra (PEN) | United States | $8.954B | 87.71 |
Masimo (MASI) | United States | $7.672B | 41.09 |
Glaukos (GKOS) | United States | $7.241B | 0.00 |
PROCEPT BioRobotics (PRCT) | United States | $4.816B | 0.00 |
Integer Holdings (ITGR) | United States | $4.241B | 24.04 |
Inari Medical (NARI) | United States | $2.853B | 0.00 |
LivaNova (LIVN) | United Kingdom | $2.776B | 16.03 |
TransMedics (TMDX) | United States | $2.765B | 87.66 |
Veracyte (VCYT) | United States | $2.635B | 163.38 |
Nihon Kohden (NHNKY) | Japan | $2.558B | 15.91 |
Elekta AB (EKTAY) | Sweden | $2.267B | 18.47 |
Tandem Diabetes Care (TNDM) | United States | $2.089B | 0.00 |
RxSight (RXST) | United States | $1.890B | 0.00 |
Integra LifeSciences Holdings (IART) | United States | $1.496B | 6.81 |
Alphatec Holdings (ATEC) | United States | $1.150B | 0.00 |
Artivion (AORT) | United States | $1.121B | 102.89 |
Pulse Biosciences (PLSE) | United States | $0.896B | 0.00 |
AVANOS MEDICAL, INC (AVNS) | United States | $0.860B | 14.62 |
Pacific Biosciences Of California (PACB) | United States | $0.665B | 0.00 |
OrthoPediatrics (KIDS) | United States | $0.663B | 0.00 |
ORTHOFIX MEDICAL INC (OFIX) | United States | $0.647B | 0.00 |
Mesa Laboratories (MLAB) | United States | $0.638B | 16.12 |
IRadimed (IRMD) | United States | $0.612B | 33.08 |
AxoGen (AXGN) | United States | $0.611B | 0.00 |
SiBone (SIBN) | United States | $0.562B | 0.00 |
Paragon 28 (FNA) | United States | $0.470B | 0.00 |
ClearPoint Neuro (CLPT) | United States | $0.356B | 0.00 |
Tactile Systems Technology (TCMD) | United States | $0.349B | 10.65 |
Treace Medical Concepts (TMCI) | United States | $0.297B | 0.00 |
CVRx (CVRX) | United States | $0.292B | 0.00 |
Delcath Systems (DCTH) | United States | $0.292B | 0.00 |
AngioDynamics (ANGO) | United States | $0.271B | 0.00 |
Sight Sciences (SGHT) | United States | $0.262B | 0.00 |
Semler Scientific (SMLR) | United States | $0.215B | 15.04 |
Nevro (NVRO) | United States | $0.206B | 0.00 |
Inogen (INGN) | United States | $0.206B | 0.00 |
NeuroPace (NPCE) | United States | $0.184B | 0.00 |
Atossa Genetics (ATOS) | United States | $0.179B | 0.00 |
Accuray (ARAY) | United States | $0.175B | 0.00 |
Alpha Tau Medical (DRTS) | Israel | $0.160B | 0.00 |
KORU Medical Systems (KRMD) | United States | $0.124B | 0.00 |
Spectral Diagnostics (EDTXF) | Canada | $0.123B | 0.00 |
908 Devices (MASS) | United States | $0.120B | 0.00 |
Sensus Healthcare (SRTS) | United States | $0.108B | 16.02 |
EDAP TMS S.A (EDAP) | France | $0.106B | 0.00 |
WORK Medical Technology Group (WOK) | China | $0.088B | 0.00 |
Monogram Orthopaedics (MGRM) | United States | $0.080B | 0.00 |
Hyperfine (HYPR) | United States | $0.071B | 0.00 |
Covalon Technologies (CVALF) | Canada | $0.067B | 0.00 |
LENSAR (LNSR) | United States | $0.062B | 0.00 |
InspireMD (NSPR) | Israel | $0.062B | 0.00 |
Envoy Medical (COCH) | United States | $0.050B | 0.00 |
Lucid Diagnostics (LUCD) | United States | $0.050B | 0.00 |
Vicarious Surgical (RBOT) | United States | $0.048B | 0.00 |
Rapid Micro Biosystems (RPID) | United States | $0.047B | 0.00 |
Accelerate Diagnostics (AXDX) | United States | $0.046B | 0.00 |
EnVVeno Medical (NVNO) | United States | $0.045B | 0.00 |
Adagio Medical Holdings (ADGM) | United States | $0.036B | 0.00 |
Neuronetics (STIM) | United States | $0.031B | 0.00 |
DarioHealth (DRIO) | United States | $0.030B | 0.00 |
Spectral AI (MDAI) | United States | $0.027B | 0.00 |
Precision Optics (POCI) | United States | $0.026B | 0.00 |
Ekso Bionics Holdings (EKSO) | United States | $0.020B | 0.00 |
Biosig Technologies (BSGM) | United States | $0.018B | 0.00 |
NexGel (NXGL) | United States | $0.018B | 0.00 |
Baird Medical Investment Holdings (BDMD) | $0.017B | 0.00 | |
Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
T2 Biosystems (TTOO) | United States | $0.015B | 0.00 |
QT Imaging Holdings (QTI) | United States | $0.015B | 0.00 |
Aspira Women's Health (AWH) | United States | $0.014B | 0.00 |
Pixie Dust Technologies (PXDT) | Japan | $0.013B | 0.00 |
Autonomix Medical (AMIX) | United States | $0.013B | 0.00 |
PAVmed (PAVM) | United States | $0.011B | 0.00 |
Check-Cap (CHEK) | Israel | $0.007B | 0.00 |
ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
Venus Concept (VERO) | Canada | $0.003B | 0.00 |
ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
Nuwellis (NUWE) | United States | $0.003B | 0.00 |
SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
Tenon Medical (TNON) | United States | $0.002B | 0.00 |
Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
Avinger (AVGR) | United States | $0.002B | 0.00 |
Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |